DNMT3A and hematologic disorder: To date, several additional DNMT3A mutations have also been associated with the development of hematological malignancies in both humans [157,158] and mice [157] with TBRS, suggesting germline DNMT3A mutations may also promote clonal hematopoiesis and AML.